✦ LIBER ✦

P-588 Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB+ IV) non-small-cell lung cancer (NSCLC). A phase II study of the Galician Lung Cancer Group

✍ Scribed by Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; Huidobro, G.; Mel, J.; Ramos, M.; Grande, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

P-526 Phase I/II study of GTI-2040 plus

✍ Leighl, N.; Laurie, S.; Knox, J.; Ellis, P.; Shepherd, F.; Burkes, R.; Pond, G.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 286 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Preliminary results of a phase II random

✍ Marangolo, M; Cognetti, F; Di Costanzo, F; Selvaggi, G; Scagliotti, G.V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A multicenter phase II trial with gemcit

✍ E. Laack; T. Mende; J.G. Saal; A. Chemaissani; J. Scholtze; C. Lorenz; K. Dalhof 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB